Efficacy of autologous expanded bone marrow derived mesenchymal stem cells (axBM-MSC) in the treatment of patients with chron's disease who have failed to standard therapy: an open-label, randomized controlled clinical trial phase II
2013 ◽
Vol 29
(12)
◽
pp. 2020-2028
◽
2013 ◽
Vol 4
(4)
◽
pp. 229
◽
2010 ◽
Vol 202
(3)
◽
pp. 392-398
◽
2018 ◽
Vol 22
◽
pp. 54-61
◽
2017 ◽
Vol 8
(2)
◽
pp. 42-45
◽